FY2025 Earnings Forecast for PRE Issued By Cantor Fitzgerald

Prenetics Global Limited (NASDAQ:PRE) – Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Prenetics Global in a note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn anticipates that the company will post earnings of ($2.08) per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $9.00 price target on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share.

Prenetics Global (NASDAQ:PRE) last posted its earnings results on Wednesday, November 27th. The company reported ($0.84) earnings per share for the quarter. Prenetics Global had a negative return on equity of 16.45% and a negative net margin of 191.73%.

Prenetics Global Trading Up 0.1 %

Prenetics Global stock opened at $5.73 on Wednesday. The firm has a market capitalization of $52.33 million, a price-to-earnings ratio of -1.43 and a beta of -0.30. The firm has a 50 day simple moving average of $5.31 and a 200 day simple moving average of $5.09. Prenetics Global has a 1-year low of $2.85 and a 1-year high of $7.84.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.